Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole — Stella

Home/Chronic Pulmonary Aspergillosis/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Pulmonary Aspergillosis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

France

CHU Poitiers, Poitiers

Key details

Phase

Large-scale testing

Sponsor

Poitiers University Hospital

Enrollment target

~224 participants

Started

December 2018

Primary completion

June 2027

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.